Renal “hyperfiltrators” are at elevated risk of death and chronic diseases by unknown
Altay et al. BMC Nephrology 2014, 15:160
http://www.biomedcentral.com/1471-2369/15/160RESEARCH ARTICLE Open AccessRenal “hyperfiltrators” are at elevated risk of
death and chronic diseases
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Background: The definition of glomerular hyperfiltration has not been agreed upon and the pathophysiological
mechanisms have not been well explored. Low serum creatinine concentrations may be associated with increased
risk of coronary heart disease (CHD) or cardiopulmonary events the impact of which needs further study.
Methods: Consecutive applicants to a cardiovascular hospital free of moderate/severe chronic kidney disease (age
55.6 ± 8.2 years) were grouped into those without (“healthy”, n = 469) and with CHD (320 stable and acute coronary
syndrome cases) at baseline and into sex-specific quartiles of CKD-EPI equation-estimated glomerular filtration rate
(eGFR). New or recurrent cardiovascular (myocardial infarction, stroke, heart failure [HF]) events, obstructive pulmonary
disease (COPD) and death were determined during 3-years’ follow-up.
Results: Among 25 deaths and 75 cardiopulmonary events, HF was the leading nonfatal event. Age, serum uric
acid and left ventricular ejection fraction proved the best independent inverse covariates of eGFR in the “healthy”
sample. The highest eGFR quartile (“hyperfiltrators”), exhibiting significantly lower serum LDL-cholesterol levels,
significantly predicted the combined outcome (at a RR of 6) in “healthy” subjects, after adjustment for sex, age,
body mass index, smoking status and presence of hypertension. This finding was paralleled by the highest eGFR
quartile calculated also by the MDRD equation, replicating this also in the CHD group.
Conclusion: Renal “hyperfiltrators” represent individuals with autoimmune activation (involving serum creatinine,
partly escaping assay), are misclassified into optimal renal function and actually are at significantly higher risk of
death, HF or cardiopulmonary events. Low serum creatinine levels may represent a clue to the existence of
autoimmune activation.
Keywords: Autoimmune activation, Cardiovascular disease, Chronic obstructive pulmonary disease, Glomerular
filtration rate, Heart failure, Renal hyperfiltrationBackground
Renal hyperfiltration has been described to occur in renal
and non-renal clinical conditions [1,2]. The definition of
glomerular hyperfiltration has not been agreed upon
and the pathophysiological mechanisms have not been
well explored [1], yet a glomerular filtration rate (GFR)
125 to 140 ml/min per 1.73 m2, or >2 SD above mean
GFR in healthy individuals is a commonly adopted def-
inition [2,3]. In humans, renal hyperfiltration observed
in early diabetes mellitus is a risk factor for the devel-
opment of diabetic nephropathy [4]. More recently,
renal hyperfiltration has been reported in obesity and* Correspondence: svtaltay@gmail.com
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unless otherwise stated.the metabolic syndrome (MetS) [5-8]. In subjects with im-
paired fasting glucose, hyperfiltration occurred before the
diagnosis of type-2 diabetes [7]. A “physiological” state of
glomerular hyperfiltration occurs during pregnancy and
after consumption of high-protein meals [1].
The pathogenesis of hyperfiltration is incompletely
understood and attributed in diabetes to glomerular af-
ferent and efferent arteriolar tone as well as to tubular
factors; others have proposed a tubuloglomerular feed-
back hypothesis (reviewed in Ref. 2).
Information on the clinical significance and pathophysi-
ology of glomerular hyperfiltration was extended by evi-
dence reported in middle-aged Turkish adults [9] that low
(as well as high) levels of creatinine (or “hyperfiltration”)
were independently associated with future coronary heartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ascribed the low measurements to partial inability to assay
circulating creatinine, secondary to involvement in auto-
immune activation. The group of the Turkish Adult Risk
Factor (TARF) study later demonstrated that CHD likeli-
hood in women in the lowest creatinine quartile was asso-
ciated with CHD risk even in non-diabetic subjects
without MetS [10], indicating that the underlying patho-
logic process had its onset already in “apparently healthy”
female population at large.
Serum creatinine was not the only polypeptide/protein
that was presumably comprised in autoimmune activation.
Evidence for the involvement of other proteins such as
lipoprotein[Lp] (a) [11] was available in the TARF cohort
or of cystatin C and glycated hemoglobin in studies from
other populations, upon which a unifying hypothesis of
autoimmune activation underlying diverse chronic dis-
eases was put forward by Onat and Can [12], further ex-
plained in the Discussion.
We aimed in this study to test in a community-based
sample undergoing health checks at a large tertiary cardio-
vascular center whether subjects with low serum creatin-
ine (or elevated eGFR, “hyperfiltrators”): a) had normal or
increased risk for mortality and/or cardiovascular and
chronic pulmonary events at an intermediate follow-up
period, and b) which clinical and laboratory risk profile
characterized them at baseline. These we analyzed after
stratifying the study sample into quartiles of eGFR and the
presence or absence of CHD which partly included cases
of acute coronary syndrome (ACS). For estimating GFR,
we have evaluated both the Modification of Diet in Renal
Disease (MDRD) [13] and the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) [14] equations.
Methods
Study sample
The baseline study sample is formed by consecutive out-
patients and patients admitted in the first quarter of year
2010 to the S. Ersek Center for Cardiovascular Surgery
who had no missing values for serum creatinine concen-
trations. This sample was drawn from a total of 1900 pa-
tients applying in the stated period. For reasons of lower
risk of cardiopulmonary events or confounding problems
of potential comorbidity, subjects aged <40, or >72 years
and those with greater than mild renal dysfunction
(<60 ml/min per 1.73 m2) (n = 207), decompensated heart
failure (n = 120) and uncontrolled diabetes (HbA1c >10%;
n = 92) were excluded, as were subjects with missing cre-
atinine values (n = 494). This left 789 individuals to form
the study sample. Follow-up consisted of up to 3.0 years.
The study was approved by the Institutional Ethics
Committee of the Dr. Siyami Ersek Training Research
Hospital Center. Data recorded in the hospital charts
were obtained.Consent statement
As this study is a retrospective study, informed consent
was not obtained from the patients.
Measurement of risk factors
Blood pressure (BP) was measured with an aneroid sphyg-
momanometer (Erka, Germany) in the sitting position on
the right arm, and the mean of at least two recordings
5 min apart was registered. Body mass index (BMI) was
computed from values of weight/height squared. Never,
former and current smokers formed the categories of
cigarette smoking.
Blood samples, collected after an overnight fast, were
spun at 1000 g, and analyzed in a central laboratory. All
laboratory determinations were performed using Siemens
Healthcare Diagnostic Products kits and calibrators
(Marburg, Germany). Serum creatinine concentrations
were measured with the Jaffe method having a lower
detection limit of 0.1 mg/dl and uric acid with the uri-
case method. Serum concentrations of total cholesterol,
triglycerides and glucose were measured enzymatically.
LDL- and high-density lipoprotein (HDL)-cholesterol were
quantified directly with the elimination catalase method
and Advia autoanalyzer. Concentrations of HbA1c were
measured in whole blood agglutination inhibition and
serum CRP with Latex-enhanced immunoturbidimetry.
Sixty-four percent of the study participants underwent
two-dimensional and Doppler echocardiography by an
experienced specialist using a Vivid 3 (GE Healthcare
Systems, Piscataway, New Jersey, USA) device. Left ven-
tricular ejection fraction (LVEF) was calculated using the
modified Simpson’s method.
Definitions
GFR (in ml/min per 1.73 m2) was estimated using a) the
equation proposed by CKD-EPI for white females and
males [14] which uses truncation for low creatinine values,
and b) the abbreviated equation developed by the MDRD
[13] = (186.3 * (serum creatinine)–1.154 * age–0.203 * 0.742
[for women]). Hypertension was defined as a blood pres-
sure ≥140 mmHg and/or ≥90 mmHg, and/or use of anti-
hypertensive medication. Diabetes type-2 was diagnosed
with the criteria of the American Diabetes Association
[15]. CHD was diagnosed by a history of myocardial in-
farction and revascularization, by angiographic greater
than 50% stenosis of at least one major coronary artery.
Outcome
Information on cause of death was drawn from hospital
records during follow-up, from records of the nation-
wide Identity Sharing System, or from first-degree rela-
tives. Follow-up for mortality was complete via the Identity
Sharing System which registers all deaths by using identity
numbers for each citizen; causes were identified from
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formation on nonfatal events at follow-up was obtained (in
70%) from hospital records at their return visits to the
medical center, and the remainder by phone from close rel-
atives of patients, Stroke was defined as affected impair-
ment of brain function having resulted in an inability to
move a limb, or inability to understand or formulate
speech. Congestive heart failure (HF) was diagnosed when
typical symptoms (e.g. breathlessness, ankle swelling, and
fatigue) and signs (e.g. elevated jugular venous pressure,
pulmonary crackles, and displaced apex beat) due to an
abnormality of cardiac structure. Chronic obstructive pul-
monary disease (COPD) designated patients who had no
evidence of this at baseline but received this diagnosis in
the follow-up period in our out-patient chest clinic, based
on obstructive findings in pulmonary function testing and
in whom bronchodilator drugs were initiated.
Data analysis
Descriptive parameters were shown as mean (±standard
deviation [SD]) or in percentages. Due to skewed distribu-
tion, geometric means were used for CRP values. Two-
sided t-tests and Pearson’s chi-square tests were used to
analyze the differences between means and proportions of
variables within quartiles of eGFR and by pairwise com-
parisons with post hoc Tukey homogeneous subsets
(HSD) tests. The development of multiple cardiopulmo-
nary events in an individual was counted only as one sub-
ject, or in the case of death as death alone. Rather than
defining fixed cutoffs for hyperfiltration for which unan-
imity is lacking, we formed sex-specific quartiles of eGFR
defined by each equation. Cutoff points were 60–88, up to
99, up to 110, and >110 ml/min per 1.73 m2 for CKD-EPI,Figure 1 Depicts graphically the median, 2.5 and 97.5 percentile GFR
subjects and in those with CHD, free of chronic kidney disease, strati
equation-derived estimates only in quartiles 4 (depicted in thick lines) of he
serum creatinine is little involved in an autoimmune complex in men durinwhile these were <83.6/<82.6, up to 100/105, up to 132/
141.9, >132/≥142 ml/min per 1.73 m2, respectively, for
men/women in the MDRD formula. A multiple linear re-
gression model, selected from findings of univariate cor-
relation, was analyzed to seek best independent covariates
of eGFR. Logistic regression analyses were used for com-
bined endpoint of death and incident cardiovascular and
pulmonary events (MI, HF, stroke and COPD) for eGFR
quartiles formed by the two sets of cutoffs. Risk esti-
mates (RR) and 95% confidence intervals (CI) were ob-
tained in models that adjusted for sex, age and relevant
confounders, expressed in terms of 1-SD increment. A
value of p < 0.05 on the two-tail test was considered sta-
tistically significant. Statistical analyses were performed
using SPSS-10 for Windows.
Results
The study sample consisted of 403 women (age 55.9 ± 8.4)
and 386 men (age 55.3 ± 8.0), age range 40 to 72 years.
Median, 2.5 and 97.5 percentile eGFR values estimated by
the MDRD and CKD-EPI equations in healthy subjects
free of chronic kidney disease and those with (stable and
acute) CHD are presented graphically in Figure 1, strati-
fied by gender. CHD was diagnosed at baseline in 222
men and 98 women. Diabetes was identified at baseline in
213 subjects (27%). A total of 25 deaths and 75 instances
of nonfatal MI, HF, stroke and COPD events occurred in
100 unique subjects during a follow-up of up to 3.0 (me-
dian 1.8) years. Additional instances of HF, nonfatal MI,
stroke and COPD identified in patients who died or sus-
tained an AMI were not included in analyses.
Table 1 shows prevalence of type-2 diabetes, clinical and
biochemical data at baseline, stratified to presence ofvalues estimated by the MDRD and CKD-EPI equations in healthy
fied by gender. Noteworthy is that differences exist between the two
althy adults and in females, but not males with CHD, implicating that
g the development of CHD.
Table 1 Baseline characteristics of the study sample, by presence of baseline CHD and GFR quartiles estimated by
CKD-EPI equation (n = 789)
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Ren. fnct. Mild dysfnct. Normal Normal “Hyperfiltrator”
n Mean ± SD Mean ± SD Mean ± SD Mean ± SD p-value
No CHD (n = 469)
Sex, n, M/F 164/305 41/76 42/77 40/76 41/76 1.00
eGFR,ml/min per 1.73 m2 74 ± 8.6 93.7 ± 4 104.2 ± 3.3 117.3 ± 6.8
Creatinine, mg/dl 0.947 ± 0.14 .763 ± 0.14 .642 ± 0.14 .534 ± 0.11
Age, yrs 59.7 ± 6.8 57.4 ± 7.4 54.6 ± 8 47.8 ± 6 <0.001
BMI, kg/m2 28 ± 4 27.8 ± 3.1 27.2 ± 4 27.1 ± 3.8 0.20
Systolic BP, mmHg 129.4 ± 20 126 ± 19 125.6 ± 20 123.8 ± 19 0.16
Diastolic BP, mmHg 79.3 ± 10.4 77.7 ± 12 78.4 ± 10.4 75.9 ± 9.7 0.10
Total cholest, mg/dl 448 214 ± 49 213.5 ± 48 212 ± 47 198 ± 43 0.042
LDL cholest, mg/dl 445 132 ± 39 130.5 ± 38 129 ± 39 112.5 ± 32.4 <0.001
HDL cholest, mg/dl 448 53.1 ± 13.5 53.2 ± 13.4 49.6 ± 14 47.6 ± 16 0.007
F.triglycerides, mg/dl 448 154 ± 72 157 ± 82 162 ± 97 195 ± 149 0.014
Fast glucose, mg/dl 467 110 ± 30 115 ± 52 117 ± 43 117 ± 34 0.51
HbA1c,%l 423 5.98 ± 0.8 5.95 ± 1.1 6.06 ± 1.1 5.91 ± 1.13 0.75
Uric acid, mg/dl 385 5.43 ± 1.1 5.2 ± 1.3 4.97 ± 1.2 4.79 ± 1.17 0.001
C-reactive protein,¶ mg/L 371 2.42 x2.74 2.64 x2.64 2.61 x2.61 2.38 x2.39 0.81
Current; past smokers,% 15.2; 29.8 22.6; 19.3 27.6; 17.5 34.8; 33.3 <0.001
LV ejection fraction,% 273 60.5 ± 7 60.1 ± 6 59.3 ± 5.7 57.2 ± 11 0.058
Diabetes baseline, n,% 22; 18.8 23; 19.3 30; 25.9 26; 22.2 0.54
CHD (n = 320) Ren. fnct. Mild dysfnct. Normal Normal “Hyperfiltrator”
Sex, n, M/F 222/98 54/27 49/26 58/25 61/20 0.53
eGFR,ml/min per 1.73 m2 320 74.3 ± 8 93 ± 3.6 103.6 ± 3.6 115.3 ± 6
Creatinine, mg/dl 1.02 ± 0.15 0.81 ± 0.14.6 0.673 ± 0.14 0.589 ± 0.103
Age, yrs 320 59.6 ± 7 58.7 ± 7.3 57.5 ± 7.7 50.6 ± 6.6 <0.001
BMI, kg/m2 27.5 ± 3.9 28.3 ± 4 26.9 ± 3 27.6 ± 4.1 0.14
Systolic BP, mmHg 132.8 ± 18 134 ± 17 134 ± 16.5 132.3 ± 21 0.95
Diastolic BP, mmHg 81.3 ± 11 82.2 ± 9 80.6 ± 9.9 81 ± 9.5 0.78
Total cholest, mg/dl 315 191 ± 42 195 ± 42.5 187 ± 48 193 ± 39 0.73
LDL cholest, mg/dl 312 113 ± 32 118 ± 35 112.6 ± 36 116.9 ± 36 0.71
HDL cholest, mg/dl 315 43.7 ± 12 43.8 ± 11 42.3 ± 12 41 ± 9.6 0.36
F. triglycerides, mg/dl 315 168 ± 82 168 ± 86 164 ± 93 177 ± 100 0.85
Fast glucose, mg/dl 124 ± 58 124 ± 45 129 ± 52 129.6 ± 72 0.87
HbA1c,% 312 6.27 ± 1.24 6.28 ± 1.13 6.40 ± 1.50 6.61 ± 1.69 0.40
Uric acid, mg/dl 293 5.77 ± 1.4 5.47 ± 1.2 5.21 ± 1.4 5.26 ± 1.15 0.038
C-reactive protein,¶ mg/L 291 3.20 x3.2 3.35 x2.7 3.25 x3.37 4.24 x3.5 0.41
Current; past smokers,% 33.3; 45.7 44; 37.3 47; 37.3 55.6; 31.3 0.21
LV ejection fraction,% 243 51 ± 11.7 51.3 ± 11.4 51.8 ± 10 49.3 ± 11.6 0.63
Diabetes baseline, n,% 27; 33.3 27; 36 30; 36.1 28; 34.6 0.98
¶log-transformed values, SD range is obtained by dividing or multiplying with the given SD.
Numbers in boldface denote significant difference from Q2.
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of CHD at baseline, the distribution of sex and diabetes
was similar across the quartiles. The highest eGFR quartile
differed from Q2 or Q3, the normal renal function group,
in being younger, having significantly lower LDL-, HDL-,
and total cholesterol, uric acid levels, and higher fasting
triglycerides and tended to lower LVEF. In patients with
prevalent CHD, significant difference across the quartiles
was confined to the “hyperfiltrating” quartile displaying
significantly younger age and lower uric acid levels.
Number of subjects deceased or having incurred cardio-
pulmonary events at follow-up are provided in Table 2, by
presence of CHD and quartiles of eGFR. MI, heart failure
and cancer constituted the majority of causes of deaths.
Of the 13 cases of new COPD identified in the follow-up
(including one as cause of death) only 3 men and one
woman were current smokers, whereas 9 men and women
were never or former smokers.
Serum uric acid best covariate of eGFR
Five variables showing highest univariate correlations with
eGFR were included in a multiple linear regression model
to determine its independent covariates (Table 3). Using
eGFR derived from both equations in highly significant re-
gression models, serum uric acid levels proved a highly
significant inverse covariate in the “healthy” group, inde-
pendent of BMI and apart from age. LVEF was associated
inversely with eGFR, significantly in the “healthy” group,
tended weakly so in the CHD group.
Logistic regression for outcome
Table 4 shows predictors of combined outcome (death
and nonfatal cardiopulmonary events) among the groups
without and with CHD at baseline using the same re-
gression model with eGFR derived from two equations.
Among the “healthy” group, beyond age and former
smoking, highest eGFR quartile with the MDRD equa-
tion significantly predicted the combined outcome at a
RR of 4.00 (95%CI 1.34; 11.9) compared to the normal
Q2, while sex, BMI and presence of hypertension didTable 2 Number of individuals free of or with coronary heart
cardiopulmonary events at follow-up, stratified to quartiles o
Total “healthy” sample
Total subjects p = 0.37 Deaths Nonfatal Eve
Quartile 1 117 1 4
Quartile 2 119 4 4
Quartile 3 116 6 3
Quartile 4 117 5 7
Grand total 469 16¶ 18*
*As nonfatal events heart failure occurred in 13, chronic obstructive pulmonary dise
‡ Nonfatal myocardial infarction (MI) in 23, heart failure in 24, COPD in 8, stroke in
¶ Death was due to MI in 6, heart failure in 5 patients, stroke and COPD in 2 patien
amputation in 1 patient each. Cause remained obscure in 2 instances.not reach significance. RR with the CKD-EPI was 2.94
(whereby p-trend =0.048), or attained a p = 0.006 when
expressed using Q1 as referent (Table 4). Highest eGFR
quartile significantly predicted outcome among patients
with CHD at an RR 2.72 (95% CI 1.08; 6.81) yet only
with the MDRD estimate, not with that of CKD-EPI.
Discussion
This study confirmed in middle-aged hospital applicants
what has recently been proposed in a general population
sample of Turkish adults, namely, that “hyperfiltrators”
(usually persons with low serum creatinine) are actually
at elevated cardiovascular risk. When stratified into
quartiles of GFR estimated by the CKDI-EPI equation,
“hyperfiltrators” in the “healthy” sample, were signifi-
cantly younger, more frequently former smokers, had
higher plasma atherogenic index (triglyceride/HDL-C ra-
tio) and lower LDL-cholesterol, uric acid and LVEF, des-
pite having similar BMI, compared to subjects with
normal renal function. We are the first to determine
prospectively that the highest eGFR quartile independ-
ently predicted the combined outcome of total death
and cardiopulmonary events at roughly a 3-fold relative
risk, irrespective of estimating GFR by the CKD-EPI or
the MDRD equation. The risk profile among “hyperfil-
trators” suggested an underlying autoimmune activation
involving serum creatinine which rendered partial escape
from immunoassay leading to misclassification of sub-
jects having (seemingly paradoxically) elevated cardio-
vascular risk.
Higher eGFR in females but “hyperfiltrators” comprise
males as well
Individuals included in CKDI-EPI-derived eGFR Q2 or
Q3 may be considered to represent normal renal func-
tion, displaying a range of 88–110 ml/min per 1.73 m2.
Healthy females had eGFR similar to men while females
with CHD had even somewhat higher eGFR than men,
although in the general TARF sample [16] they had one-
tenth lower values than men. This current finding isdisease (CHD) at baseline who died or incurred
f eGFR (by CKD-EPI)
CHD at baseline






ase (COPD) in 5 (all in quartiles 3 & 4) unique subjects
2 subjects.
ts each, lung cancer in 4, breast cancer in 2 patients, cardiomyopathy and leg
Table 3 Linear regression analysis for independent association with eGFR¶ using MDRD equation
Free of CHD, n = 221* With CHD, n = 220*
ß coeff. SE p-value ß coeff. SE p-value
Age, 8 years −12.5 2.6 <0.001 −8.7 2.8 0.02
Uric acid, 1 mg/dl −6.4 2.1 <0.001 −3.4 1.57 0.03
Diastolic b. pressure, 10 mmHg −1.0 2.5 0.69 3.5 2.9 0.091
Body mass index, 4 kg/m2 −3.7 3.1 0.23 −4.0 2.3 0.093
LV ejection fraction, 10% −11.1 3.3 0.001 −3.9 1.9 0.059
r2 18%, p < 0.001 7.5%, p = 0.001
eGFR with CKD-EPI
Age, 8 years −9.6 1.0 <0.001 −7.5 1.0 <0.001
Uric acid, 1 mg/dl −3.0 0.8 0.001 −1.7 0.8 0.035
Diastolic b. pressure, 10 mmHg −0.03 1.0 0.97 2.0 1.0 0.047
Body mass index, 4 kg/m2 −1.1 1.2 0.34 −3.6 1.1 0.20
LV ejection fraction, 10% −4.4 1.3 0.001 −1.4 0.9 0.12
r2 37%, p < 0.001 22%, p < 0.001
*Limited by unavailable values for mainly left ventricular (LV) ejection fraction and, partly, serum uric acid.
CHD, coronary heart disease Numbers in boldface denote significantly associated values.
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to autoimmune activation than men, with resultant ap-
parent “hyperfiltration” [12].
The current study demonstrates that, in a sample of
subjects undergoing health checks, men as well are subject
to Lp (a)-activated autoimmunity comprising serum cre-
atinine. By showing similar distribution of the two GFR
estimates across the quartiles in men with CHD, this study
supported the conclusion by the TARF [9,10] that, in con-
trast to females, serum creatinine is little involved in an
autoimmune complex in men during the development of
CHD, but is rather so in healthy men mainly regarding
other outcomes such as heart failure, stroke and COPD.
Rationale for including COPD as an outcome target
Although tobacco smoking is a major risk factor for
COPD, recent evidence suggests that other risk factors
are important as well, especially in developing countries
[17]. One-third of patients with COPD are estimated to
be never smokers but are thought to be exposed to bio-
mass fumes [18-20], air pollutants, etc. Beyond this, en-
hanced pro-inflammatory state associated with obesity
might result also in COPD among non-smokers, a ten-
dency reported among Korean men [20]. On this postu-
late, we included COPD in this study as a potentially
informative outcome and observed that all 5 cases of
newly developing COPD in the “healthy” group belonged
to baseline eGFR quartiles 3 and 4.
It is worth pointing out in this context that discontinu-
ance of smoking was a significant predictor of combined
outcome events in the multivariable regression model,
suggesting inhibition of autoimmune processes by active
smoking and being in line with the findings andinterpretation regarding autoimmune type-2 diabetes de-
veloping in Norwegian men and women [21].
Further distinctive risk profile of “hyperfiltrators”
That low serum creatinine was not due to low muscle
mass associated with end-stage renal disease, or advanced
heart failure, can be inferred from the younger age, similar
BMI and LVEF of hyperfiltrators compared to participants
in the remaining categories. Furthermore, a “reverse caus-
ality” is highly unlikely due to the prospective design of
the study. Multiple linear analyses indicated that BMI was
not independently related to hyperfiltration. Conversely,
these patients were not undernourished, as evidenced by
their being overweight in general. They were associated
with atherogenic (high triglyceride/low HDL-cholesterol)
dyslipidemia and exhibited, notably, lower concentrations
of LDL- and total cholesterol than subjects with normal
eGFR, similar to the large Swedish AMORIS study cohort
[22] in which the overwhelming majority with a normal
eGFR had 12% lower LDL- and total cholesterol values
than those with mildly reduced eGFR. Yet when classified
into quartiles, multivariable adjustment revealed in the
highest eGFR quartile higher risk for all-cause mortality
than the optimal risk quartile (>96 ml/min vs. 85–
96 ml/min per 1.73 m2) and for incident MI than all
the remaining eGFR quartiles.
Lower uric acid values among “hyperfiltrators” suggest
the concomitant involvement in the immune complex of
uric acid as well, for which some evidence was previously
found in Turkish women [23,24]. This consideration is in
agreement with a large prospective study in Taiwan report-
ing that sex- and age-adjusted hazard ratios of uric acid
levels for overall mortality were increased, also for uricemia
Table 4 Logistic regression models for combined death
and nonfatal events, stratified by presence of CHD at
baseline, comparing eGFR with both the MDRD and
CKD-EPI equations
Free of CHD CHD
RR 95% CI RR 95% CI
Combined events/Total at risk 34/469 66/320
eGFR with MDRD
Sex, male 1.32 0.61; 2.85 1.16 0.60; 2.24
Age, 8 years 1.53 1.03; 2.32 1.71 1.24; 2.35
eGFR Quartile 1*, 69 ml/min/ 0.78 0.21; 2.86 1.85 0.75; 4.53
eGFR Quartile 3*, 115 ml/min/ 2.25 0.94; 6.88 2.28 0.96; 5.42
eGFR Quartile 4*, 163 ml/min/ 4.00 1.34; 11.9 2.72 1.08; 6.81
Hypertension, yes/no 1.34 0.62; 2.89 0.83 0.46; 1.49
Body mass index, 4 kg/m2 1.06 0.71; 1.57 1.23 0.91; 1.64
Current vs never smoking 1.37 0.52; 3.57 1.06 0.45; 2.50
Former vs never smoking 2.85 1.08; 7.56 1.06 0.45; 2.49
eGFR with CKD-EPI
Sex, male 1.31 0.61; 2.80 0.85 0.44; 1.62
Age, 8 years 1.78 1.13; 2.85 1.73 1.22; 2.48
eGFR Quartile 2*, 94 ml/min/1.73 2.07 0.64; 6.68 1.05 0.48; 2.31
eGFR Quartile 3*, 104 ml/min/1.73 2.84 0.87; 9.22 1.45 0.58; 3.11
eGFR Quartile 4*, 118 ml/min/1.73 6.08Ť 1.68; 22.0 1.36 0.55; 3.34
Hypertension, yes/no 1.30 0.61; 2.78 0.83 0.47; 1.48
Body mass index, 4 kg/m2 1.02 0.69; 1.53 1.20 0.90; 1.60
Current vs never smoking 1.30 0.51; 3.37 0.98 0.42; 2.29
Former vs never smoking 2.74 1.05; 7.18 0.98 0.42; 2.28
*Referent is expressed for quartile 2 in the upper, for quartile 1 (70 ml/min/) in
the lower model.
Number of subjects in the group without and with CHD, respectively: 151/181
hypertensives; 164/144 current and 57/121 former smokers. CHD, coronary
heart disease Ť p trend 0.048.
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were both younger and had lower serum uric acid are in
line with recently reported observations among Turks that
uric acid was independently and linearly associated with
serum total phospholipids in men and women without
MetS and that the concentration of phospholipids on HDL
predicted the development of MetS [24], thus supporting a
notion that –similar to creatinine– reduced uric acid level
may be due to partial inability to assay, secondary to auto-
immune activation. Puddu and Menotti [26] stressed that
“serum uric acid might be considered for risk predictive
purposes to be incorporated into software instruments
aimed at indexing and/or following up individuals for pri-
mary preventive purposes.”
“Hyperfiltrators”, characterized by high serum triglyc-
erides, suggested the presence of low circulating Lp(a) –
by virtue of having damaged epitope that partly escapes
immunoassay. Such an autoimmune “pattern” has been
reported in the TARF study [12,27]. Reduced levels ofLDL-cholesterol have been reported to similarly precede
the clinical onset of rheumatoid arthritis [28]. Epidemio-
logical data showing paradoxical inverse association of
lipid levels with cardiovascular disease risk in rheuma-
toid arthritis patients have been reviewed [29]. Further-
more, high serum triglycerides headed the determinants of
a new cardiovascular event n 700 Swedish early rheuma-
toid arthritis patients [30].
Noteworthy is that the characteristics of atherogenic
dyslipidemia and reduced LVEF of “hyperfiltrators” be-
came diluted in the subset with baseline CHD, since
CHD patients with normal renal function not only had
diminished LVEF but also low total and LDL-cholesterol
and a higher proportion of atherogenic dyslipidemia,
eliminating the differences from the “hyperfiltrators”.
Explanation of current results
Present findings support the hypothesized notion [12,27]
that autoimmune activation associated with enhanced
low-grade inflammation is a common mechanistic path-
way leading to diverse chronic diseases, foremost to dia-
betes, CHD and CKD. Serum creatinine, a tripeptide, may
undergo oxidative damage to its epitope alike circulating
a), be perceived as a foreign body, partly lose assayability
and may aggregate to autoimmune components such as
apoA-I [11] and/or adiponectin. Immune complexes with
ß2-glycoprotein I-Lp (a) have been reported in patients
with coronary artery disease [31]. The related individual is
necessarily categorized into the lowest creatinine (or high-
est eGFR quantile), despite likely harboring a milieu of
oxidative stress, HDL dysfunction and autoimmune acti-
vation associated with elevated cardiorenal-metabolic risk.
The reduced LVEF, along with our observation of HF as
the most common consequence among “healthy” “hyper-
filtrators”, suggests that such autoimmune activation fre-
quently leads to HF the prevalence of which has been
increasing in the community [32]. Cancer formed the sec-
ond frequent death cause, being in line with a recent
community-based case–control study that patients with
heart failure have an increased risk of incident cancer [33],
suggesting a common underlying mechanism.
Implications
The magnitude of relative risk it conferred in this sample,
and the substantial proportion in the population at large,
necessitate the identification of potential “hyperfiltrators”
in the community which has both methodological and
clinical implications. One implication concerns the equa-
tion selected for estimating GFR, since the CKD-EPI [14],
more suited to estimate creatinine-based GFR for the
general population, tends to conceal “hyperfiltrators” by
truncating creatinine values <0.7/<0.9 mg/dl. The MDRD
estimate has the advantage of disclosing apparent “hyperfil-
trators”, as can be inferred from analyzing eGFR quartiles
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ted above.
For clinically suspecting “hyperfiltrating” individuals,
we may propose as a rough guide for 55-year old Turks
an eGFR of >120/110 ml/min per 1.73 m2 (or serum
creatinine <0.72 and <0.60 mg/dl) in men and women,
respectively. The need for better understanding the
mechanisms involved in renal hyperfiltration has been
emphasized in order to develop new therapeutic strat-
egies [1]. Much further research is warranted in this
area in different ethnicities.Limitations and strength
The size of the study sample and the duration of the
follow-up period are relatively limited which, however,
did not preclude the emergence of significant results in
the sample. Applicability of current findings, especially
the extent of such in other ethnicities remains to be con-
firmed, but arguments may apply to similar findings
among Swedes [22]. Given that underlying pathways ex-
amined here had already been published in representa-
tive samples of Turkish adults, we generated congruent
results in patients suspected of heart disease undergoing
health checks. Findings regarding COPD, obviously, may
be considered only as preliminary and hypothesis generat-
ing. Strength of the study is its unique longitudinal design,
as well as the stratified analyses of a sample susceptible to
pro-inflammatory state, the availability of various clinical,
lipid and inflammation biomarkers, including LVEF, thus
supporting and confirming a novel hypothesis. The salient
information provided by the concomitant evaluation of
GFR estimates and their relative predictive value of se-
lected outcomes is thus far unique.Conclusions
A sample of applicants of health check-up demonstrated
that creatinine-based renal “hyperfiltrators prevailed in ex-
cess of one-third of the sample. They were characterized,
not by a higher BMI, but by being younger and more fre-
quently former smokers, having lower serum total and
LDL-cholesterol, uric acid and LVEF, and a higher propor-
tion of atherogenic dyslipidemia than persons with normal
eGFR. Logistic regression models using two different
creatinine-based eGFR at follow-up revealed significantly
raised relative risk for combined death, cardiovascular and
pulmonary events, above all HF, among the “hyperfiltra-
tors” than in the subsets with normal eGFR, after adjust-
ment for BMI and traditional cardiovascular risk factors.
We conclude that the fundamental oxidative stress and
autoimmune process simultaneously render partial es-
cape of serum creatinine from full assay and impart excess
risk of chronic cardiometabolic, renal and pulmonary
morbidity and mortality. Clinicians need to be aware thatunexpectedly low serum creatinine levels may represent a
clue to the existence of autoimmune activation.
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